Dr. Kenneth Graham is board certified by the American Board of Ophthalmology. He engages in research, and with his partners has participated in numerous clinical trials, including the initial development of Lucentis and Avastin.
Dr. Kenneth Graham is board certified by the American Board of Ophthalmology. He engages in research, and with his partners has participated in numerous clinical trials, including the initial development of Lucentis and Avastin.
Dr. Kenneth Graham graduated summa cum laude with a bachelor’s degree in microbiology from the University of Alabama. He was given a full scholarship to the University of Alabama School of Medicine and was awarded a two-year research scholarship by the Howard Hughes Medical Institute to conduct research at the National Institutes of Health. After medical school, Dr. Graham moved to Rochester, Minnesota, to complete an internship in medicine at the Mayo Clinic. For ophthalmology residency training, he studied at Harvard Medical School/Massachusetts Eye and Ear Infirmary. He continued at Harvard to complete a two-year fellowship in diseases of the retina, and he served as Chief Fellow during his final year. While working at Harvard Medical School with Dr. Joan Miller and Dr. Evangelos Gragoudas on new treatments for Age-Related Macular Degeneration, Dr. Graham was awarded both the Heed Foundation and Herman Knapp Scholarships. Before coming to New York, Dr. Graham was in private practice for two years in Baltimore where he served as Instructor of Ophthalmology for Wilmer Eye Institute/Johns Hopkins Medical School. Dr. Graham is board certified by the American Board of Ophthalmology. He is a member of the American Society of Retina Specialists, the American Academy of Ophthalmology, the Medical Society of the State of New York, and the Long Island Ophthalmological Society. He served as past president of the Suffolk County Ophthalmological Society. Dr. Graham continues to engage in research, and with his partners has participated in numerous clinical trials, including the initial development of Lucentis and Avastin. Dr. Graham served as principal investigator for the phase 3 clinical trial for Brolucizumab. His areas of expertise include the medical and surgical management of retinal detachments, diabetic retinopathy, macular degeneration, macular holes, and vein occlusions. Dr. Graham and his wife have been married since 1994 and have four children - two sons and twin daughters. Dr. Graham has enjoyed coaching soccer for his daughters and serving as Cubmaster as well as Scoutmaster for his sons in Boy Scouts. Dr. Graham and both of his sons are Eagle Scouts. Training Fellowship in Medical and Surgical Retina, Harvard Medical School/Massachusetts Eye and Ear Infirmary, Boston, MA Residency in Ophthalmology, Harvard Medical School/Massachusetts Eye and Ear Infirmary, Boston, MA Internship in Internal Medicine, Mayo Clinic, Rochester, MN Doctor of Medicine, University of Alabama School of Medicine, Birmingham, AL
Very professional and informative on my condition
very personable...explains to my mom the problem in a way that she can understand. Very patient!
He’s wonderful..
Very satisfied.
Completely satisfied
Excellent doctor Explain all procedures in detail and always follow up with progress ❤️
Execellent!!
Six stars if there was more I could do more very professional
Exam was thorough but quick (for an eye exam). Very clear comments about what is going on with my eyes, what to watch for and what to do if I have future symptoms.
Proactive and efficient.